In addition, the PAK6-SIRT4-ANT2 complex inhibited apoptosis in prostate cancer cells, and SIRT4 deprived ANT2 acetylation at the K105 site and promoted ubiquitinated degradation of ANT2. This evidence concerns the gene SIRT4 and prostate cancer.